MFSD2B

gene
On this page

Also known as SLC59A2

Summary

MFSD2B (MFSD2 lysolipid transporter B, sphingolipid, HGNC:37207) is a protein-coding gene on chromosome 2p23.3, encoding Sphingosine-1-phosphate transporter MFSD2B (A6NFX1). Lipid transporter that specifically mediates export of sphingosine-1-phosphate in red blood cells and platelets.

Enables sphingolipid transporter activity. Involved in lipid transport. Is active in plasma membrane.

Source: NCBI Gene 388931 — RefSeq curated summary.

At a glance

  • GWAS associations: 32
  • Clinical variants (ClinVar): 64 total
  • MANE Select transcript: NM_001346880

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:37207
Approved symbolMFSD2B
NameMFSD2 lysolipid transporter B, sphingolipid
Location2p23.3
Locus typegene with protein product
StatusApproved
AliasesSLC59A2
Ensembl geneENSG00000205639
Ensembl biotypeprotein_coding
OMIM617845
Entrez388931

Gene structure

Transcript identifiers

Ensembl transcripts: 6 — 3 protein_coding, 2 retained_intron, 1 nonsense_mediated_decay

ENST00000338315, ENST00000406420, ENST00000453731, ENST00000469562, ENST00000495018, ENST00000669179

RefSeq mRNA: 1 — MANE Select: NM_001346880 NM_001346880

CCDS: CCDS86824

Canonical transcript exons

ENST00000338315 — 14 exons

ExonStartEnd
ENSE000011830982402358324023726
ENSE000011831022402313024023239
ENSE000015361402402164824021738
ENSE000015361522401728624017364
ENSE000034710722401684524016968
ENSE000034756432402243324022516
ENSE000035148272401328524013410
ENSE000035937452401745824017588
ENSE000035953672402409524024271
ENSE000036155302402184924021970
ENSE000036342472402282224022902
ENSE000036418422401615624016280
ENSE000036928512402543224026775
ENSE000039010332401008524010192

Expression profiles

Bgee: expression breadth ubiquitous, 134 present calls, max score 81.88.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 1.4601 / max 180.1310, expressed in 135 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
191661.2457133
191670.214430

Top tissues by expression

136 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
bloodUBERON:000017881.88gold quality
monocyteCL:000057679.18gold quality
bone marrowUBERON:000237178.34gold quality
leukocyteCL:000073878.29gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047376.46silver quality
bone marrow cellCL:000209273.43gold quality
thymusUBERON:000237069.18gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099168.52silver quality
stromal cell of endometriumCL:000225568.42gold quality
placentaUBERON:000198766.38gold quality
quadriceps femorisUBERON:000137765.49gold quality
granulocyteCL:000009465.33gold quality
cerebellar vermisUBERON:000472064.61gold quality
sural nerveUBERON:001548864.08gold quality
nucleus accumbensUBERON:000188263.03gold quality
skeletal muscle tissueUBERON:000113459.76gold quality
putamenUBERON:000187459.11gold quality
ganglionic eminenceUBERON:000402358.76gold quality
caudate nucleusUBERON:000187358.66gold quality
cortical plateUBERON:000534358.30gold quality
right lungUBERON:000216757.88gold quality
right coronary arteryUBERON:000162557.77gold quality
gastrocnemiusUBERON:000138857.69gold quality
muscle of legUBERON:000138357.61gold quality
muscle tissueUBERON:000238557.60gold quality
colonic epitheliumUBERON:000039757.19silver quality
adrenal tissueUBERON:001830356.67gold quality
tibial nerveUBERON:000132355.78gold quality
myometriumUBERON:000129655.26gold quality
hindlimb stylopod muscleUBERON:000425255.15gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes8.35
E-GEOD-124858no3.32

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 5)

  • Results identify Mfsd2a (major facilitator superfamily domain-containing protein 2a) and an additional closely related protein Mfsd2b, and suggest that Mfsd2a plays a role in adaptive thermogenesis. (PMID:18694395)
  • MFSD2B, CCL20 and STAT1, or STARD7 and ZNF512 genes may be risk or protect factors in prognosis of ADC; HTR2B, DPP4, and TGFBRAP1 genes may be risk factors in prognosis of SQC. (PMID:27301951)
  • Using microarray analysis of erythroid cell lines overexpressing human and mouse MFSD2B study showed sphingosine 1-phosphate (S1P) transport activity. The properties of S1P release by MFSD2B were similar to those in erythrocytes. Moreover, knockout of MFSD2B in MEDEP-E14 cells decreased S1P export from the cells. These results strongly suggest that MFSD2B is a novel S1P transporter in erythroid cells. (PMID:29563527)
  • Revealing concealed cardioprotection by platelet Mfsd2b-released S1P in human and murine myocardial infarction. (PMID:37100836)
  • An erythrocyte-centric view on the MFSD2B sphingosine-1-phosphate transporter. (PMID:37390971)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriomfsd2bENSDARG00000030263
mus_musculusMfsd2bENSMUSG00000037336
rattus_norvegicusMfsd2bENSRNOG00000023508
caenorhabditis_elegansWBGENE00017530

Paralogs (2): MFSD12 (ENSG00000161091), MFSD2A (ENSG00000168389)

Protein

Protein identifiers

Sphingosine-1-phosphate transporter MFSD2BA6NFX1 (reviewed: A6NFX1)

Alternative names: Major facilitator superfamily domain-containing protein 2B

All UniProt accessions (4): A0A2I3JL00, A6NFX1, A0A590UK14, H7BZN4

UniProt curated annotations — full annotation on UniProt →

Function. Lipid transporter that specifically mediates export of sphingosine-1-phosphate in red blood cells and platelets. Sphingosine-1-phosphate is a signaling sphingolipid and its export from red blood cells into in the plasma is required for red blood cell morphology. Sphingosine-1-phosphate export from platelets is required for platelet aggregation and thrombus formation. Mediates the export of different sphingosine-1-phosphate (S1P) species, including S1P(d18:0) (sphinganine 1-phosphate), S1P (d18:1) (sphing-4-enine 1-phosphate) and S1P (d18:2) (sphinga-4E,14Z-dienine-1-phosphate). Release of sphingosine-1-phosphate is facilitated by a proton gradient. In contrast, cations, such as sodium, are not required to drive sphingosine-1-phosphate transport. In addition to export, also able to mediate S1P import. Does not transport lysophosphatidylcholine (LPC).

Subcellular location. Cell membrane.

Similarity. Belongs to the major facilitator superfamily.

RefSeq proteins (1): NP_001333809* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR036259MFS_trans_sfHomologous_superfamily
IPR039672MFS_2Family

Pfam: PF13347

Catalyzed reactions (Rhea), 3 shown:

  • sphing-4-enine 1-phosphate(in) = sphing-4-enine 1-phosphate(out) (RHEA:38667)
  • sphinganine 1-phosphate(in) = sphinganine 1-phosphate(out) (RHEA:38671)
  • sphinga-4E,14Z-dienine-1-phosphate(in) = sphinga-4E,14Z-dienine-1-phosphate(out) (RHEA:70207)

UniProt features (18 total): transmembrane region 10, mutagenesis site 3, region of interest 2, compositionally biased region 2, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-A6NFX1-F180.820.46

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Mutagenesis-validated functional residues (3):

PositionPhenotype
95abolishes export of sphingosine-1-phosphate.
157abolishes export of sphingosine-1-phosphate.
423does not affect export of sphingosine-1-phosphate.

Function

Pathways and Gene Ontology

Reactome pathways

4 pathways

IDPathway
R-HSA-1660661Sphingolipid de novo biosynthesis
R-HSA-1430728Metabolism
R-HSA-428157Sphingolipid metabolism
R-HSA-556833Metabolism of lipids

MSigDB gene sets: 86 (showing top): GOBP_REGULATION_OF_CELL_ACTIVATION, GOBP_CARBOHYDRATE_TRANSPORT, GOBP_SPHINGOLIPID_MEDIATED_SIGNALING_PATHWAY, GOBP_PLATELET_ACTIVATION, GOBP_POSITIVE_REGULATION_OF_CELL_ADHESION, GOBP_WOUND_HEALING, GOBP_CELL_CELL_ADHESION, GOBP_REGULATION_OF_PLATELET_AGGREGATION, GOBP_SPHINGOLIPID_METABOLIC_PROCESS, GOBP_LIPID_METABOLIC_PROCESS, GOBP_LIPID_BIOSYNTHETIC_PROCESS, GOBP_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION, GOBP_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION, REACTOME_SPHINGOLIPID_METABOLISM, GOBP_HOMOTYPIC_CELL_CELL_ADHESION

GO Biological Process (6): sphingosine-1-phosphate receptor signaling pathway (GO:0003376), lipid transport (GO:0006869), carbohydrate transport (GO:0008643), sphingolipid biosynthetic process (GO:0030148), transmembrane transport (GO:0055085), positive regulation of platelet aggregation (GO:1901731)

GO Molecular Function (2): symporter activity (GO:0015293), sphingolipid intramembrane carrier activity (GO:0046624)

GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)

Reactome top-level categories

Rollup of top-3 pathways:

CategoryPathways
Sphingolipid metabolism1
Metabolism of lipids1
Metabolism1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
transport3
G protein-coupled receptor signaling pathway1
sphingolipid mediated signaling pathway1
lipid localization1
sphingolipid metabolic process1
lipid biosynthetic process1
cellular process1
positive regulation of homotypic cell-cell adhesion1
platelet aggregation1
regulation of platelet aggregation1
secondary active transmembrane transporter activity1
intramembrane lipid carrier activity1
membrane1
cell periphery1
cellular anatomical structure1

Protein interactions and networks

STRING

594 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
MFSD2BSPNS2Q8IVW8990
MFSD2BSPNS1Q9H2V7857
MFSD2BSPHK1Q9NYA1718
MFSD2BSPHK2Q9NRA0696
MFSD2BS1PR2O95136691
MFSD2BS1PR3Q99500658
MFSD2BS1PR5Q9H228603
MFSD2BS1PR4O95977582
MFSD2BAPOMO95445571
MFSD2BSLC33A2Q96ES6560
MFSD2BSGPL1O95470541
MFSD2BSPNS3Q6ZMD2541
MFSD2BSLC67A2Q8NBP5540
MFSD2BMFSD11O43934521
MFSD2BSLC75A1Q14728513

IntAct

4 interactions, top by confidence:

ABTypeScore
MFSD2BUSP33psi-mi:“MI:0915”(physical association)0.400
HIF1AMFSD2Bpsi-mi:“MI:0915”(physical association)0.400
MFSD2BTNFRSF10Bpsi-mi:“MI:0914”(association)0.350

BioGRID (15): MFSD2B (Affinity Capture-RNA), ARHGEF1 (Affinity Capture-MS), ATP11C (Affinity Capture-MS), ATP6V0A1 (Affinity Capture-MS), ATP6V0A2 (Affinity Capture-MS), CR2 (Affinity Capture-MS), ENPP1 (Affinity Capture-MS), ERLIN2 (Affinity Capture-MS), KDM5C (Affinity Capture-MS), MARCH5 (Affinity Capture-MS), MARVELD2 (Affinity Capture-MS), PTPRJ (Affinity Capture-MS), RETSAT (Affinity Capture-MS), TMEM33 (Affinity Capture-MS), TNFRSF10B (Affinity Capture-MS)

ESM2 similar proteins: A0A3Q2HW92, A6NDV4, A6NFX1, A6QLK4, B1AWJ5, F1NCD6, F1NJ67, F1PZV2, O35308, O35595, O70461, O95907, Q08DX7, Q0IHM1, Q0P5C0, Q0P5M9, Q13286, Q14728, Q29611, Q2YDU8, Q3T9M1, Q3U481, Q501I9, Q5R8G5, Q5R9A1, Q5U419, Q60HH0, Q61124, Q66H95, Q6NUT3, Q6UXD7, Q6ZMD2, Q7RTT9, Q8BFQ6, Q8CE47, Q8NA29, Q8R0G7, Q8R139, Q8TB61, Q8VCW4

Diamond homologs: A4IH46, A6NFX1, F1NCD6, Q0IHM1, Q3T9M1, Q5U3U7, Q6DEJ6, Q8NA29, Q9DA75

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

64 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance57
Likely benign6
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

3730 predictions. Top by Δscore:

VariantEffectΔscore
2:24010192:GGTG:Gdonor_loss1.0000
2:24010193:G:GAdonor_loss1.0000
2:24010194:T:Gdonor_loss1.0000
2:24017365:G:GGdonor_gain1.0000
2:24017589:G:GGdonor_gain1.0000
2:24022817:CACA:Cacceptor_loss1.0000
2:24022820:AGGT:Aacceptor_loss1.0000
2:24022901:TT:Tdonor_gain1.0000
2:24022901:TTGTG:Tdonor_loss1.0000
2:24022903:G:GGdonor_gain1.0000
2:24022903:G:Tdonor_loss1.0000
2:24022907:G:GGdonor_gain1.0000
2:24023578:CGCA:Cacceptor_loss1.0000
2:24023579:GCA:Gacceptor_loss1.0000
2:24023580:CAGG:Cacceptor_loss1.0000
2:24023581:AGGT:Aacceptor_loss1.0000
2:24023582:GGTCC:Gacceptor_gain1.0000
2:24023724:GGA:Gdonor_gain1.0000
2:24023725:GA:Gdonor_gain1.0000
2:24023725:GAG:Gdonor_gain1.0000
2:24023727:G:GGdonor_gain1.0000
2:24023738:GGT:Gdonor_gain1.0000
2:24024090:TCCA:Tacceptor_loss1.0000
2:24024092:CAGG:Cacceptor_loss1.0000
2:24024093:A:AGacceptor_gain1.0000
2:24024093:A:Cacceptor_loss1.0000
2:24024093:AG:Aacceptor_gain1.0000
2:24024094:G:GAacceptor_gain1.0000
2:24024094:GG:Gacceptor_gain1.0000
2:24024094:GGTT:Gacceptor_gain1.0000

AlphaMissense

3203 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
2:24017458:G:CR184P0.993
2:24013390:T:CF68L0.991
2:24013392:C:AF68L0.991
2:24013392:C:GF68L0.991
2:24023211:A:CS381R0.991
2:24023213:C:AS381R0.991
2:24023213:C:GS381R0.991
2:24022837:A:CS332R0.988
2:24022839:C:AS332R0.988
2:24022839:C:GS332R0.988
2:24023206:G:AG379D0.986
2:24016891:T:AW132R0.985
2:24016891:T:CW132R0.985
2:24022849:T:AW336R0.985
2:24022849:T:CW336R0.985
2:24023205:G:CG379R0.983
2:24022457:T:CF307L0.982
2:24022459:C:AF307L0.982
2:24022459:C:GF307L0.982
2:24013331:G:AG48D0.981
2:24013330:G:CG48R0.980
2:24013363:A:CS59R0.980
2:24013365:C:AS59R0.980
2:24013365:C:GS59R0.980
2:24021963:C:AA296D0.980
2:24017490:G:AG195R0.978
2:24017490:G:CG195R0.978
2:24024195:G:AG472R0.978
2:24024195:G:CG472R0.978
2:24013391:T:CF68S0.977

dbSNP variants (sampled 300 via entrez): RS1000012917 (2:24025943 C>A,T), RS1000066663 (2:24020894 T>A), RS1000234531 (2:24018215 G>A), RS1000287005 (2:24018000 A>G), RS1000442489 (2:24024011 G>A,C,T), RS1000567147 (2:24019685 T>C,G), RS1000741968 (2:24016731 C>T), RS1001198494 (2:24010243 A>G), RS1001239095 (2:24016936 A>T), RS1001394910 (2:24022964 T>C), RS1001605012 (2:24016739 A>G), RS1001780971 (2:24022716 G>C), RS1002215889 (2:24010022 G>A,C,T), RS1002287741 (2:24018062 T>G), RS1002682295 (2:24020968 C>T)

Disease associations

OMIM: gene MIM:617845 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

32 associations (top):

StudyTraitp-value
GCST004609_136Monocyte percentage of white cells4.000000e-21
GCST004611_7High light scatter reticulocyte count4.000000e-26
GCST004612_164High light scatter reticulocyte percentage of red cells1.000000e-29
GCST004619_48Reticulocyte fraction of red cells9.000000e-20
GCST004622_148Reticulocyte count2.000000e-15
GCST004627_136Lymphocyte count9.000000e-40
GCST004628_142Immature fraction of reticulocytes5.000000e-27
GCST004632_126Lymphocyte percentage of white cells7.000000e-13
GCST006268_492Reaction time5.000000e-08
GCST008163_219Height3.000000e-07
GCST012126_2hemolysis of donated blood (osmotic)5.000000e-08
GCST012135_2hemolysis of donated blood (osmotic)1.000000e-13
GCST90002385_118High light scatter reticulocyte count9.000000e-31
GCST90002386_236High light scatter reticulocyte percentage of red cells8.000000e-25
GCST90002386_237High light scatter reticulocyte percentage of red cells4.000000e-16
GCST90002387_251Immature fraction of reticulocytes2.000000e-11
GCST90002387_252Immature fraction of reticulocytes3.000000e-27
GCST90002388_64Lymphocyte count1.000000e-60
GCST90002388_65Lymphocyte count2.000000e-10
GCST90002389_103Lymphocyte percentage of white cells7.000000e-16
GCST90002397_765Mean spheric corpuscular volume2.000000e-59
GCST90002397_791Mean spheric corpuscular volume4.000000e-09
GCST90002399_158Neutrophil percentage of white cells3.000000e-17
GCST90002400_557Plateletcrit2.000000e-11
GCST90002400_558Plateletcrit2.000000e-09
GCST90002403_75Red blood cell count3.000000e-41
GCST90002405_112Reticulocyte count3.000000e-16
GCST90002405_113Reticulocyte count1.000000e-10
GCST90002406_7Reticulocyte fraction of red cells6.000000e-19
GCST90002406_8Reticulocyte fraction of red cells7.000000e-12

EFO canonical traits (10, from GWAS)

EFO IDTrait name
EFO:0007989monocyte percentage of leukocytes
EFO:0007986reticulocyte count
EFO:0004587lymphocyte count
EFO:0007993lymphocyte percentage of leukocytes
EFO:0008393reaction time measurement
EFO:0009473hemolysis
EFO:0007990neutrophil percentage of leukocytes
EFO:0007985platelet crit
EFO:0004305erythrocyte count
EFO:0007788BMI-adjusted waist-hip ratio

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: transporter — SLC59 Sodium-dependent lysophosphatidylcholine symporter family

CTD chemical–gene interactions

8 total (human), top 8 by PubMed support.

ChemicalActions (top 5)PubMed papers
aristolochic acid Iincreases expression1
triphenyl phosphateaffects expression1
bisphenol Adecreases methylation1
abrineincreases expression1
Benzo(a)pyreneaffects methylation, decreases methylation1
Smokedecreases expression1
Urethanedecreases expression1
Valproic Acidincreases methylation1

Cellosaurus cell lines

2 cell lines: 2 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_D4GLHCT116-MFSD2B-KO-c17Cancer cell lineMale
CVCL_D4GMHCT116-MFSD2B-KO-c21Cancer cell lineMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.